Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mochida

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mochida's Japan sales performance.

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

The combination is approved in both the EU and Japan for specific patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results

Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results Presently, Dupixent is approved in Europe, the US, Japan and other countries worldwide for use in specific patients with moderate-to-severe atopic dermatitis, as well as certain patients with asthma

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug as we do in the US and Japan,” he added.

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement.

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China Japan’s medicines regulator.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....